Anaplastic Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Anaplastic Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]
This entry reports an ongoing Phase II clinical trial evaluating pembrolizumab in patients with metastatic or locally advanced anaplastic/un…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial [Phase 1]
Phase 1 feasibility trial evaluating repurposed drugs for thyroid carcinoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) [Phase 2]
Phase 2 clinical trial NAVIGATION is evaluating nivolumab in combination with lenvatinib for anaplastic thyroid carcinoma; the study is curr…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer [Phase 1]
Phase 1 clinical trial testing dabrafenib and trametinib with IMRT in patients with BRAF-mutated anaplastic thyroid carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC [Phase 2]
This Phase II IMPAACT trial evaluated adjuvant pembrolizumab after IMRT in anaplastic thyroid carcinoma. The study was terminated, and resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. [Phase 2, Phase 3]
The DETERMINE trial's Arm 07 is studying dabrafenib plus trametinib in patients with BRAF V600 mutation-positive cancers across age groups; …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with dabrafenib and trametinib before surgery for BRAF-mutated anaplastic thyroid carc…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial update for lenvatinib plus pembrolizumab in stage IVB unresectable or stage IVC metastatic anaplastic thyroid cance…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]
First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab with chemotherapy for anaplastic and poorly differentiated thyroid carcinoma; the study is active but …
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. [Phase 2, Phase 3]
Phase 2/3 DETERMINE trial treatment arm 05 is evaluating the combination of vemurafenib and cobimetinib in adults with BRAF-positive cancers…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors [Phase 1]
Phase 1 study evaluating CFT1946 as monotherapy and in combination for BRAF V600-mutant solid tumors to assess safety, tolerability, and pre…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]
Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC [Phase 2]
Phase 2 clinical trial evaluating MRG003 in combination with pucotenlimab for anaplastic thyroid carcinoma and poorly differentiated thyroid…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating selpercatinib given before surgery for RET-altered thyroid cancers is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: XL092 and Cemiplimab in BRAF WT Thyroid Cancer [Phase 1]
Phase 1 trial update for XL092 in combination with cemiplimab in BRAF wild-type thyroid cancers, including anaplastic thyroid carcinoma, is …
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer [Phase 2]
Phase 2 clinical trial update for Vudalimab in locally advanced or metastatic anaplastic thyroid carcinoma and oncocytic (Hurthle cell) thyr…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Taiwanese Anaplastic Thyroid Cancer Registry
A Taiwanese clinical trial registry for anaplastic thyroid carcinoma is reported and is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer [Phase 2]
Phase II trial of tunlametinib in NRAS-mutant advanced thyroid cancer is currently recruiting, evaluating differentiated, poorly differentia…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of cemiplimab with dabrafenib and trametinib in patients with anaplastic thyroid…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC [Phase 1, Phase 2]
This clinical trial investigates combining NKG2D CAR-NK cell therapy with a PD-1 monoclonal antibody to treat anaplastic thyroid carcinoma. …
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating intensity-modulated radiation therapy and paclitaxel with or without pazopanib for anaplastic thyroid carcinoma has…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC) [Phase 2]
Phase 2 trial of lenvatinib for anaplastic thyroid carcinoma was terminated with results posted in 2019.